Abstract
An allo-SCT is therapeutic option in management of both newly diagnosed and relapsed patients with a diagnosis of acute lymphoblastic leukemia (ALL). There is limited data from developing countries on the role of allo-SCT for this indication.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
